Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership3,250 shares
Latest Disclosed Value $ 56,257
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 12.15% increase in ownership of APLS / Apellis Pharmaceuticals, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 3,250 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $56,257 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 2,898 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of 12.15% during the quarter. The current value of the position is $133,348 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Apellis Pharmaceuticals EC US03753U1060 3,250 352 12.15 56 -11.11 0.6252
2025-05-29 2025-03-31 NP Apellis Pharmaceuticals EC US03753U1060 2,898 269 10.23 63 -24.10 0.6733
2025-03-03 2024-12-31 NP Apellis Pharmaceuticals EC US03753U1060 2,629 -79 -2.92 84 6.41 0.8410
2024-11-29 2024-09-30 NP Apellis Pharmaceuticals EC US03753U1060 2,708 305 12.69 78 -15.22 0.7074
2024-08-29 2024-06-30 NP Apellis Pharmaceuticals EC US03753U1060 2,403 -3 -0.12 92 -34.75 0.8404
2024-05-30 2024-03-31 NP Apellis Pharmaceuticals EC US03753U1060 2,406 231 10.62 141 8.46 1.1994
2024-02-29 2023-12-31 NP Apellis Pharmaceuticals EC US03753U1060 2,175 -889 -29.01 130 12.07 1.0671
2023-11-29 2023-09-30 NP Apellis Pharmaceuticals EC US03753U1060 3,064 882 40.42 117 -41.41 1.0092
2023-08-28 2023-06-30 NP Apellis Pharmaceuticals EC US03753U1060 2,182 -330 -13.14 199 20.00 1.5687
2023-05-30 2023-03-31 NP Apellis Pharmaceuticals EC US03753U1060 2,512 -1,438 -36.41 166 -19.12 1.2550
2023-02-28 2022-12-31 NP Apellis Pharmaceuticals EC US03753U1060 3,950 827 26.48 204 -4.23 1.2352
2022-11-29 2022-09-30 NP Apellis Pharmaceuticals EC US03753U1060 3,123 -343 -9.90 213 36.54 1.4885
2022-08-29 2022-06-30 NP Apellis Pharmaceuticals EC US03753U1060 3,466 -195 -5.33 157 -16.13 1.0753
2022-05-26 2022-03-31 NP Apellis Pharmaceuticals EC US03753U1060 3,661 -901 -19.75 186 -13.49 1.0992
2022-02-28 2021-12-31 NP Apellis Pharmaceuticals EC US03753U1060 4,562 -58 -1.26 216 41.45 0.9531
2021-11-29 2021-09-30 NP Apellis Pharmaceuticals EC US03753U1060 4,620 4,620 152 0.6401
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.